1 янв 2014 г. - $100 million from Alexion Pharmaceuticals
Описание:
Alexion Pharmaceuticals paid Moderna $100 million for ten product options to develop rare disease treatments, including for Crigler-Najjar syndrome, using Moderna's mRNA therapeutics platform
Добавлено на ленту времени:
Дата: